Enteral Pentobarbital in the Difficult to Sedate Critically Ill Children

Area of Science:

• Pediatric Critical Care Medicine
• Pharmacology
• Anesthesiology

Background:

• Difficult analgosedation is a frequent challenge in the pediatric intensive care unit (PICU).
• First-line sedative agents may become insufficient for managing critically ill pediatric patients.
• Exploring alternative and supplemental sedatives is crucial for optimizing patient care.

Purpose of the Study:

• To evaluate the safety and efficacy of enteral pentobarbital as an adjunctive sedative in difficult-to-sedate pediatric patients.
• To assess the impact of enteral pentobarbital on the requirement for other sedatives.

Main Methods:

• Retrospective chart review of 13 mechanically ventilated, critically ill children requiring enhanced sedation.
• Administration of intermittent enteral pentobarbital doses.
• Comparison of sedation scores and cumulative doses of opioids, benzodiazepines, and alpha-2 agonists before and after pentobarbital initiation.

Main Results:

• Enteral pentobarbital was associated with improved sedation (lower State Behavioral State scores) in 8 of 13 patients.
• Adjunctive pentobarbital led to reduced average doses of opioids (11% decrease), benzodiazepines (5% decrease), and alpha-agonists (20% decrease).
• No adverse events were attributed to pentobarbital administration.

Conclusions:

• Enteral pentobarbital appears to be a safe and effective adjunctive agent for managing difficult-to-sedate critically ill children.
• This approach may help reduce the overall sedative burden in this patient population.
• Further research could explore optimal dosing and long-term outcomes.